Using Triamcinolone Acetonide to Reduce Pain After Scleral Buckle Surgery
Status:
Recruiting
Trial end date:
2023-07-03
Target enrollment:
Participant gender:
Summary
PURPOSE: Scleral buckle surgery is a widely used ophthalmic surgery for the correction of
rhegmatogenous retinal detachment. Studies suggest that eye pain is a common and
underestimated occurrence after scleral buckle surgery, but as of yet, there is no definitive
management method for reducing pain following scleral buckle surgery. The investigators aim
to control pain following scleral buckle surgery with sub-tenon's irrigation with
triamcinolone acetonide at the time of surgery. Using a randomized prospective clinical
study, the investigators test if this technique will reduce the pain, nausea/vomiting, and
analgesic use caused by scleral buckle surgery.
METHODS: Forty-eight patients undergoing scleral buckle surgery will be randomized into two
groups. The experimental group receives a sub-tenon irrigation of 1 cc 40mg/mL triamcinolone
acetonide around the base of the scleral buckle (0.25 cc in each quadrant) at time of
operation. The control group does not receive any triamcinolone irrigation. Pain scores are
measured 1 day post-operatively via 11-pt numerical rating scale as the primary outcome. The
nausea/vomiting score is measured 1 day post-operatively via standard 6-pt scale. Patients
track pain medication use via pill count. Values will be measured again at 1-2-week and 6
months post-op.
Phase:
Phase 4
Details
Lead Sponsor:
Virginia Polytechnic Institute and State University